How bisoprolol is better than nebivolol?

Bisoprolol and nebivolol are both beta-blockers used to treat hypertension and heart conditions, but bisoprolol is often preferred for its well-established efficacy in reducing cardiovascular events and its predictable pharmacokinetics. It has a longer half-life, allowing for once-daily dosing, which can enhance patient adherence. Additionally, bisoprolol has been extensively studied in various populations, providing a robust evidence base for its use in heart failure and other conditions. However, the choice between the two ultimately depends on individual patient needs and response to treatment.